Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension

7680679870017 CH-67987 Pulver
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
1 / 3
google

Article details

Package size
1 + 1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
11/07/2026
Summary of Product Characteristics
Français
11/07/2026
Summary of Product Characteristics
Italien
11/07/2026

Detailed composition

Substance Quantity Type Category
glycoproteini E viri Varicellae Zoster antigenum
50.0 UG Substance Wirkstoff (Principe actif)
adeps A 3-O-desacyl-4’-monophosphorylatus
- Substance HNIDK
glycoproteini E viri Varicellae Zoster antigenum
50.0 UG Substance Wirkstoff (Principe actif)
Quillajae saponariae Molina saponinum purificatum
- Substance HNIDK
saccharum
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
1,2-dioleoyl-sn-glycero-3-phosphocholinum
- Substance HNIDK
cholesterolum
- Substance HNIDK
adeps A 3-O-desacyl-4’-monophosphorylatus
- Substance HNIDK
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
dikalii phosphas anhydricus
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
Quillajae saponariae Molina saponinum purificatum
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
1,2-dioleoyl-sn-glycero-3-phosphocholinum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
cholesterolum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrii dihydrogenophosphas anhydricus
- Substance HNIDK
dikalii phosphas anhydricus
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.77 MG Substance HBESI
kalium
0.18 MG Substance HBESI

Reimbursement information

Public price
CHF 166.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2022

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
67987
Drug name
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
Galenic form
PULVS
ATC Code
J07BK03
Authorization status
Z
Dispensing category
B
First authorization
07/10/2021
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
Prävention von Herpes Zoster

Package details

Description (FR)
SHINGRIX subst sèche c solv (susp) flac 0.5 ml
Description (DE)
SHINGRIX Trockensub c Solv (Susp) Durchstf 0.5 ml
Market launch
07/10/2021
Narcotic (BTM)
No

Other package sizes (1)

SHINGRIX subst sèche c solv (susp) 10 x 0.5 ml
10 + 10 DUR
GTIN: 7680679870024
View
Buy us a coffee Explore the data